HURA (TuHURA) Pangali Forward P/E

Simbol resmi perusahaan TuHURA Biosciences (HURA)

TuHURA Biosciences, Inc. (HURA) is implementing AI-powered automated cell analysis systems to accelerate preclinical testing. Stock price fluctuations with the 0.00 metric reflect the specifics of a sector where demand for therapy remains stable, and security values depend on laboratory breakthroughs rather than macroeconomic trends. The business focuses on developing advanced oncology treatments and providing patient support.

tuhurabio.com - Pangali Forward P/E HURA (periode 04.07.2022 - 17.11.2026)

Ringkesan rincian data analitis TuHURA Biosciences (HURA)

Ringkesan analisis perusahaan:TuHURA Biosciences Inc. HURA
Produk merek tuhurabio.com

Forward P/E assesses the current share price relative to projected earnings, accounting for the viability of the business model. This metric determines the extent of the premium paid for future income amid market volatility. For TuHURA Biosciences, Inc. (HURA), the forward P/E is critical, as the company consumes capital for clinical trials without generating operating revenue. This chart reveals a defensive discount amid rising liquidity shortage risks, which creates a high-risk investment profile.

Analisis perusahaan pesaing

Pangali Forward P/E ONC|HALO (Halozyme Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (revmed.com)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Bio (BCAX) - Rega marang bathi mangsa ngarep|Personalis Corp - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Systems, Inc. DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Corp)|Pangali Forward P/E Aura Bio (AURA)|Pangali Forward P/E CADL (Candel Therapeutics Inc.)|ARAY - Prakiraan rega marang bathi|SLS - Rega marang bathi mangsa ngarep|Actuate Therapeutics - Rasio kapitalisasi marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|TARA: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi FATE|WHWK: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi TCRX (TScan Therapeutics Inc)|Kapitalisasi marang proyeksi bathi Champions Oncology Inc|Pangali Forward P/E XBIT (XBiotech Inc.)|Pangali mangsa ngarep rega marang bathi CVM|OS Therapies Inc. - Pangali Forward P/E|RADX - Pangali Forward P/E|ARTV: Pangali Forward P/E|ANL: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi VERU|TPST: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep xiliotx.com (XLO)|Renovaro - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Mural Oncology MURA|KAPA - Prakiraan rega marang bathi|OKUR - Rega marang bathi mangsa ngarep|GDTC - Pangali Forward P/E|Curis, Inc. (CRIS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Apollomics, Inc.|Prakiraan rega marang bathi THAR|Rasio rega marang bathi mangsa ngarep ADVB (Advanced Biomed)|Prakiraan rega marang bathi GNPX (Genprex, Inc)|CLDI: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep sunshinebiopharma.com SBFM|XBIO - Prakiraan rega marang bathi|SLRX: Prakiraan rega marang bathi|Purple Biotech - Rasio kapitalisasi marang bathi mangsa ngarep|American Oncology Network (AONC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep BGNE|Prakiraan rega marang bathi CKPT|Rega marang bathi mangsa ngarep ELEV|Pangali Forward P/E ICAD|Pangali Forward P/E Ikena Oncology Inc. (IKNA)|Pangali Forward P/E NTBL (Notable Labs Ltd)|Kapitalisasi marang proyeksi bathi Viracta Therapeutics (VIRX)|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E